Previous 10 | Next 10 |
NEW YORK, NY / ACCESSWIRE / December 24, 2019 / Halper Sadeh LLP, a global investor rights law firm, continues to investigate the following companies: Synthorx , Inc. (NASDAQ:THOR) The investigation concerns whether Synthorx and its board of directors violated the federal securities law...
Synthorx (NASDAQ: THOR ) reveals in a filing that it received a $70/share bid after it had accepted Sanofi's (NASDAQ: SNY ) $68 offer. More news on: Synthorx, Inc., Sanofi, Healthcare stocks news, Stocks on the move Read more ...
Sanofi ( SNY ) announced that it had acquired Synthorx, Inc. ( THOR ) for approximately $68 per share in cash, for a total value of $2.5 billion. This is a solid deal for Sanofi, because it will allow the company to obtain a drug known as THOR-707, which holds promise as a next generat...
NEW YORK, Dec. 21, 2019 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, continues to investigate the following companies: Audentes Therapeutics, Inc. (NASDAQ: BOLD) The investigation concerns whether Audentes and its board of directors violated the federal se...
Aimmune Therapeutics (NASDAQ: AIMT ) initiated with Neutral rating and $33 (4% upside) price target at H.C. Wainwright. More news on: Aimmune Therapeutics, Inc., Ampio Pharmaceuticals, Inc., Apellis Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move, , Read more ...
Merger activity decreased with four new deals announced and two deals closing. Deal Statistics: New Deals: The acquisition of Diplomat Pharmacy (DPLO) by OptumRx for $300 million or $4.00 per share in cash. The acquisition of Synthorx (THOR) by Sanofi (SNY) for $2.35 billio...
NEW YORK, Dec. 16, 2019 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, continues to investigate the following companies: Audentes Therapeutics, Inc. (NASDAQ: BOLD) The investigation concerns whether Audentes and its board of directors violated the federal secu...
As the year comes to a close, Sanofi (NASDAQ: SNY) has a holiday gift for investors in the form of a new strategy. The French drugmaker announced a $2.5 billion biotech takeover in the growing immuno-oncology field earlier this week, then a day later said it is dropping research in the dia...
NEW YORK, NY / ACCESSWIRE / December 13, 2019 / Juan Monteverde , founder and managing partner at Monteverde & Associates PC , a national securities firm headquartered at the Empire State Building in New York City, is investigating: Synthorx, Inc ( THOR ) relating to its sa...
NEW YORK, NY / ACCESSWIRE / December 12, 2019 / Juan Monteverde , founder and managing partner at Monteverde & Associates PC , a national securities firm headquartered at the Empire State Building in New York City, is investigating: William Lyon Homes ( WLH ) related to its...
News, Short Squeeze, Breakout and More Instantly...
The U.S. Securities and Exchange Commission (SEC) got a win in its case against Thor Technologies for an unauthorized sale of $2.6 million in&...
AMC Theatres (NYSE: AMC) has reported domestic and global success on its busiest weekend of 2022 so far from Thursday July 7th through Sunday July 10th. This was led by the opening weekend of Thor: Love and Thunder as the box office was propelled by several summer blockb...
Thor Industries (NYSE: THOR ) , a recreational vehicle maker, reported better-than-expected quarterly earnings Wednesday amid high demand for its products. The manufacturer reported earnings of USD6.32 per share, compared to the expected USD...